April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Efficacy, Safety, And Survival Rates Of Iop-lowering Effect Of Phacoemulsification Alone Or With Canaloplasty In Glaucoma Patients
Author Affiliations & Notes
  • Stella N. Arthur
    Ophthalmology, Indiana University, Indianapolis, Indiana
  • Darrell WuDunn
    Ophthalmology, Indiana University, Indianapolis, Indiana
  • Louis B. Cantor
    Ophthalmology, Indiana University, Indianapolis, Indiana
  • Guruprasad R. Pattar
    Ophthalmology, Indiana University, Indianapolis, Indiana
  • Yara Catoira-Boyle
    Ophthalmology, Indiana University, Indianapolis, Indiana
  • Linda S. Morgan
    Ophthalmology, Indiana University, Indianapolis, Indiana
  • Joni S. Hoop
    Ophthalmology, Indiana University, Indianapolis, Indiana
  • Footnotes
    Commercial Relationships  Stella N. Arthur, None; Darrell WuDunn, Pfizer (R); Louis B. Cantor, Allergan, QLT, AMO (C), Pfizer, Alcon (F); Guruprasad R. Pattar, None; Yara Catoira-Boyle, None; Linda S. Morgan, None; Joni S. Hoop, None
  • Footnotes
    Support  Unrestricted grant from Eugene and Marilyn Glick Eye Research Endowment for eye and vision research at the Indiana University Foundation.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 626. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stella N. Arthur, Darrell WuDunn, Louis B. Cantor, Guruprasad R. Pattar, Yara Catoira-Boyle, Linda S. Morgan, Joni S. Hoop; Efficacy, Safety, And Survival Rates Of Iop-lowering Effect Of Phacoemulsification Alone Or With Canaloplasty In Glaucoma Patients. Invest. Ophthalmol. Vis. Sci. 2011;52(14):626.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate efficacy, safety, and success rates of IOP-lowering effect obtained with phacoemulsification (phaco) alone or with canaloplasty (PCP) in patients with open angle glaucoma (OAG).

Methods: : Retrospective chart review of consecutive phaco from 4/30/2007 to 4/15/2010 performed by 3 surgeons (DW, LBC, and YBC) and PCP from 5/14/2007 to 7/19/2010 performed by 1 surgeon (LBC) in OAG patients. Visual acuity (VA), intraocular pressure (IOP), number of medications, and complications were analyzed. Failure criteria were: IOP more than 21 mmHg or less than 20% reduction; persistent IOP less than 6 mmHg; and loss of light perception vision.

Results: : 37 patients (16 African-Americans [AA] and 21 Caucasian [C]) underwent phaco and 32 (1 AA and 31 C) PCP. Follow-up (f/u) was 19.1±8.7 vs. 16.0±10.5 months for phaco and PCP respectively (p=0.18). Age (years) (74.7±9.8 vs. 76.4±8.4, p=0.44), gender (p=0.81), and laser status (p=0.60) were similar between 2 groups.Pre-operatively, mean±SD logMAR VA (0.5±0.7 vs. 0.5±0.5, p=0.85); IOP (16.2±4.6 vs. 18.2±5.1, p=0.10); and number of medications (1.4±1.1 vs. 1.3±0.7, p=0.88) were similar for phaco and PCP respectively.At 3 months, phaco (n=34) and PCP (n=32) mean±SD were: logMAR VA (0.2±0.2 vs. 0.3±0.3, p=0.93); IOP (14.1±3.1 vs. 12.2±3.7, p=0.03); and medications (0.9±1.0 vs. 0.1±0.3, p<0.0001).At 12 months phaco (n=34) and PCP (n=22) mean±SD were: logMAR VA (0.2±0.2 vs. 0.3±0.4, p=0.52); IOP (13.9±3.2 vs. 12.5±3.2, p=0.10); and medications (1.3±1.2 vs. 0.1±0.3, p<0.0001).At 18 months phaco (n=21) and PCP (n=14) mean±SD were: logMAR VA (0.1±0.1 vs. 0.4±0.7, p=0.10); IOP (13.5±3.5 vs. 14.1±3.6, p=0.65); and medications (1.2±1.3 vs. 0.2±0.4, p=0.03).At 24 months phaco (n=17) and PCP (n=11) mean±SD were: logMAR VA (0.2±0.2 vs. 0.5±0.8, p=0.38); IOP (14.1±3.9 vs. 13.2±3.7, p=0.56); and medications (1.6±1.2 vs. 0.3±0.5, p=0.007).Complications for phaco were IOP spikes (n=12) and for PCP were hyphema (n=7), IOP spikes (n=6) and Descement window rupture intraoperatively (n=1).Success rates for phaco vs. PCP at 12 months were 75% vs. 86%, at 18 months 56% vs. 86%, and at 24 months 50% vs. 72%. The differences were statistically significant (p=0.01).

Conclusions: : PCP had higher success rate of IOP-lowering effect than phaco alone in patients with open angle glaucoma. The use of glaucoma medications postoperatively was significantly lower with PCP than with phaco.

Keywords: treatment outcomes of cataract surgery • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×